Scrying Biotech
Long only, biotech, micro-cap, small-cap

Synergy Pharmaceuticals: There's Strength In Safety

The strong equities market of 2013 has benefited from the participation of individual investors such as myself who have arrived late in life with modest resources and great enthusiasm. We rarely buy large positions in a single trade but rather accumulate shares over time. Once enlarged, we can ill-afford to hold our equity through problematic binary events incurring massive portfolio losses.

This new investor profile of finite resources and abundant desire demands a strategy that emphasizes safety and proper timing. Reading the blueprint means identifying companies with strong financial positions, which essentially means no debt and a substantial amount of working capital preferably from recent financing activity.

Strength of Safety: Synergy's Solid Financial Position

Synergy Pharmaceuticals (SGYP) is...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
Money back guarantee. Seeking Alpha PRO members receive a no-questions-asked refund for membership on months paid and not used. Details